Beta Wealth Group, Inc. Milestone Pharmaceuticals Inc. Transaction History
Beta Wealth Group, Inc.
- $199 Million
- Q1 2025
A detailed history of Beta Wealth Group, Inc. transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Beta Wealth Group, Inc. holds 14,127 shares of MIST stock, worth $24,863. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,127
Previous 14,127
-0.0%
Holding current value
$24,863
Previous $33,000
66.67%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding MIST
# of Institutions
51Shares Held
16.8MCall Options Held
341KPut Options Held
70.3K-
Black Rock Inc. New York, NY4.97MShares$8.75 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$4.41 Million0.03% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.45MShares$2.55 Million1.35% of portfolio
-
Alta Fundamental Advisers LLC New York, NY1.43MShares$2.51 Million0.56% of portfolio
-
Bml Capital Management, LLC Zionsville, IN1.14MShares$2 Million0.74% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $52.8M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...